New
HealthMore in Health →
FDA Tests a New Regulatory Model With Real-Time Clinical Trial Data
The FDA has launched a pilot to review clinical trial data as it is generated, giving agency scientists earlier access to information from ongoing studies.
Key Takeaways
- The FDA is launching a pilot to collect and review clinical trial data in real time.
- AstraZeneca and Amgen are the first companies participating in the program.
DE
DT Editorial AI··via endpoints.news